Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register‐based cohort study
European Journal of Neurology · 2024
DOI: 10.1111/ene.16100 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Laura O'Connor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Pregnancy Outcome, Myasthenia Gravis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Scientific Research Council, Vetenskapsrådet, Grant/Award Number: VR-523-2014-2048.
Abstract (Originalsprache)
Background and Purpose Few large‐scale studies examine whether maternal myasthenia gravis (MG) is a risk factor for complications during pregnancy and childbirth. This study evaluated whether maternal MG is associated with an increased risk of adverse pregnancy, delivery, and neonatal outcomes.
Methods
We conducted a nationwide Swedish register‐based cohort study of women who gave birth to singleton infants (≥22 gestational weeks) during 1987–2019. Exposed women were diagnosed with MG before or during the index pregnancy ( N = 443). Unexposed women comprised 4249 women without a diagnosis of MG, matched for age, parity, hospital, and year of childbirth. The risks of adverse pregnancy, delivery, and neonatal outcomes for women with MG were estimated using regression modeling and presented as adjusted odds ratios (aOR).
Results
There was no increased risk of pregnancy complications in women with MG. Women with MG had a spontaneous onset of labor less often than women without MG (69.8% vs. 79.5%; aOR 0.59; p < 0.001) as well as higher labor induction rates and elective cesarean section deliveries (16.0% vs. 12.3%, aOR 1.42; p = 0.02 and 12.0% vs. 8.1%, aOR 1.59; p = 0.009). Infants of women with MG were born on average 2 days earlier ( p = 0.002); however, these infants did not have a higher risk of having low APGAR, being small for gestational age, or having a congenital malformation.
Conclusion
This first nationwide study of pregnancy in women with MG in Sweden demonstrates reassuring results overall, suggesting generally safe pregnancy outcomes for women with MG and their infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.
- Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska Institutet, and Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Anna Rostedt Punga
Förderung
- Swedish Scientific Research Council, Vetenskapsrådet, Grant/Award Number: VR-523-2014-2048
Zitieren
APA
O'Connor, L., Malmeström, C., Da Silva Rodrigues, R., Brauner, S., Wikström, A. K., & Punga, A. R. (2024). Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register‐based cohort study. European Journal of Neurology. https://doi.org/10.1111/ene.16100
Vancouver
O'Connor L, Malmeström C, Da Silva Rodrigues R, Brauner S, Wikström AK, Punga AR. Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register‐based cohort study. European Journal of Neurology. 2024. doi:10.1111/ene.16100
BibTeX
@article{OConnor2024,
author = {O'Connor, Laura and Malmeström, Clas and Da Silva Rodrigues, Rui and Brauner, Susanna and Wikström, Anna-Karin and Punga, Anna Rostedt},
title = {Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register‐based cohort study},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16100}
}
EUVIMED